UY39096A - Un método para producir una forma cristalina de 2-[(4s)-8- fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato - Google Patents
Un método para producir una forma cristalina de 2-[(4s)-8- fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidratoInfo
- Publication number
- UY39096A UY39096A UY0001039096A UY39096A UY39096A UY 39096 A UY39096 A UY 39096A UY 0001039096 A UY0001039096 A UY 0001039096A UY 39096 A UY39096 A UY 39096A UY 39096 A UY39096 A UY 39096A
- Authority
- UY
- Uruguay
- Prior art keywords
- quinazolin
- piperazin
- fluoro
- crystalline form
- metoxifenil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a un método eficaz para preparar una forma cristalina de trihidrato de sodio del ácido 2-[(4S)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4H-quinazolin-4-il]acético.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20159727 | 2020-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY39096A true UY39096A (es) | 2021-09-30 |
Family
ID=69742722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001039096A UY39096A (es) | 2020-02-27 | 2021-02-26 | Un método para producir una forma cristalina de 2-[(4s)-8- fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato |
Country Status (19)
Country | Link |
---|---|
US (1) | US20230219899A1 (es) |
EP (1) | EP4110470A1 (es) |
JP (1) | JP2023519813A (es) |
KR (1) | KR20220148863A (es) |
CN (1) | CN115581118A (es) |
AR (1) | AR121439A1 (es) |
AU (1) | AU2021225363B2 (es) |
BR (1) | BR112022016929A2 (es) |
CA (1) | CA3169484A1 (es) |
CL (1) | CL2022002291A1 (es) |
CO (1) | CO2022012039A2 (es) |
CU (1) | CU20220049A7 (es) |
EC (1) | ECSP22066680A (es) |
IL (1) | IL295795A (es) |
MX (1) | MX2022010441A (es) |
PE (1) | PE20230515A1 (es) |
TW (1) | TW202140453A (es) |
UY (1) | UY39096A (es) |
WO (1) | WO2021170874A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10319612A1 (de) | 2003-05-02 | 2004-11-18 | Bayer Healthcare Ag | Substituierte Dihydrochinazoline |
DE102012101659A1 (de) | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Salze eines Dihydrochinazolinderivats |
-
2021
- 2021-02-26 AR ARP210100497A patent/AR121439A1/es unknown
- 2021-02-26 UY UY0001039096A patent/UY39096A/es unknown
- 2021-03-01 EP EP21708227.0A patent/EP4110470A1/en active Pending
- 2021-03-01 CA CA3169484A patent/CA3169484A1/en active Pending
- 2021-03-01 WO PCT/EP2021/055045 patent/WO2021170874A1/en active Application Filing
- 2021-03-01 US US17/802,792 patent/US20230219899A1/en active Pending
- 2021-03-01 CN CN202180016769.0A patent/CN115581118A/zh active Pending
- 2021-03-01 BR BR112022016929A patent/BR112022016929A2/pt unknown
- 2021-03-01 MX MX2022010441A patent/MX2022010441A/es unknown
- 2021-03-01 CU CU2022000049A patent/CU20220049A7/es unknown
- 2021-03-01 IL IL295795A patent/IL295795A/en unknown
- 2021-03-01 KR KR1020227033588A patent/KR20220148863A/ko unknown
- 2021-03-01 JP JP2022551816A patent/JP2023519813A/ja active Pending
- 2021-03-01 PE PE2022001822A patent/PE20230515A1/es unknown
- 2021-03-01 AU AU2021225363A patent/AU2021225363B2/en active Active
- 2021-03-02 TW TW110107368A patent/TW202140453A/zh unknown
-
2022
- 2022-08-22 CL CL2022002291A patent/CL2022002291A1/es unknown
- 2022-08-24 CO CONC2022/0012039A patent/CO2022012039A2/es unknown
- 2022-08-24 EC ECSENADI202266680A patent/ECSP22066680A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP22066680A (es) | 2022-12-30 |
MX2022010441A (es) | 2022-10-18 |
TW202140453A (zh) | 2021-11-01 |
JP2023519813A (ja) | 2023-05-15 |
BR112022016929A2 (pt) | 2022-12-06 |
CU20220049A7 (es) | 2023-04-10 |
CA3169484A1 (en) | 2021-09-02 |
PE20230515A1 (es) | 2023-03-24 |
CO2022012039A2 (es) | 2022-11-18 |
EP4110470A1 (en) | 2023-01-04 |
KR20220148863A (ko) | 2022-11-07 |
AR121439A1 (es) | 2022-06-08 |
IL295795A (en) | 2022-10-01 |
US20230219899A1 (en) | 2023-07-13 |
CN115581118A (zh) | 2023-01-06 |
CL2022002291A1 (es) | 2023-02-03 |
WO2021170874A1 (en) | 2021-09-02 |
AU2021225363A1 (en) | 2022-10-13 |
AU2021225363B2 (en) | 2024-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2485825T3 (es) | Intermedio de rosuvastatina cálcica y método de preparación del mismo | |
AR084639A1 (es) | Formas polimorficas de acido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acetico y usos del mismo | |
CY1117796T1 (el) | Μετα νατριου και ασβεστιου αλατα παραγωγου διυδροκινζολινης και η χρηση αυτων ως αντι-ιικα μεσα | |
CO2019011578A2 (es) | Sal de un compuesto derivado de aminopiridina, una forma cristalina de esta, y un proceso para prepararlo | |
CU24316B1 (es) | Nuevos derivados fosfatos de 1,2,3,4-tetraisoquinolina amida fenilo, métodos de preparación de los mismos y composiciones farmacéuticas que los contienen | |
BR112015000160A2 (pt) | fabricação de ácido 2-(5-bromo-4-(4-ciclopropil hidronaftalen-1-il)-4h-1,2,4-triazol-3-il-tio) acético | |
CL2012002840A1 (es) | Procedimiento de preparacion del compuesto de fórmula (i) 4-(4-((((4-cloro-3-(trifluorometil)fenil)amino)carbonil)amino)-3-fluorofenoxi)-n-metilpiridina-2-carboxamida y sus sales a partir de 4-(4-amino-3-fluorofenoxi)-n-metilpiridina-2-carboxamida y 1-cloro-4-isocianato-2-(trifluorometil)benceno; y el compuesto de fórmula (i). | |
DOP2014000286A (es) | Compuestos de acido dimetil-benzoico | |
EA201490650A1 (ru) | Фармацевтические композиции | |
AR088018A1 (es) | Proceso e intermediarios para preparar lapatinib | |
CL2021002365A1 (es) | Forma de un compuesto que tiene biodisponibilidad mejorada y formulaciones de las mismas | |
MX2020013311A (es) | Composicion farmaceutica para administracion topica. | |
UY39096A (es) | Un método para producir una forma cristalina de 2-[(4s)-8- fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5- (trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato | |
EA201200498A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
PE20141385A1 (es) | Bloqueantes de los canales de sodio dependientes de voltaje | |
RU2009147291A (ru) | Применение ингибиторов raf для лечения рака щитовидной железы | |
EA201100230A1 (ru) | Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
ES2525528T3 (es) | Amicolamicina, método para su producción y su utilización | |
EA201301136A2 (ru) | Новый способ синтеза (2e)-3-(3,4-диметоксифенил)проп-2-еннитрила, применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
WO2014167509A3 (en) | Loxoprofen polymorphs and process for preparation of the same | |
MX2019003457A (es) | Enantiómero de ácido fenilpropiónico sustituido y método de fabricación, composición, y aplicación del mismo. | |
WO2016051422A3 (en) | Process for the preparation of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide and its polymorphs thereof | |
EA201400473A1 (ru) | Способ синтеза 3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбонитрила и применение для синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
CU20220046A7 (es) | Sal de potasio del acido 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1- il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acético y métodos para su preparación | |
GEP20156413B (en) | New process for synthesis of 3-(2-bromo-4,5-dimethoxybenzyl) propanenitrile, and application in synthesis of ivabradine and addition salts therewith pharmaceutically acceptable acid |